Monthly archive
- August 2012 (10)
- July 2012 (31)
- June 2012 (32)
- May 2012 (12)
- April 2012 (6)
- March 2012 (20)
- February 2012 (24)
- January 2012 (8)
- December 2011 (25)
- November 2011 (5)
- October 2011 (3)
- September 2011 (1)
- June 2011 (3)
-
FDA finally approves Surfaxin®
- Mar 15, 2012
-
Zimmer NexGen knee replacement causes lawsuit
- Feb 13, 2012
-
Another Canadian study confirms Actos-bladder cancer link
- Jul 9, 2012
-
New drug trio treats TB
- Jul 24, 2012
-
New tracking system may stunt prescription drug abuse
- Jul 27, 2012
-
Pradaxa and Xarelto linked to internal bleeding
- Feb 13, 2012
-
FDA issues warning after codeine kills children post-surgery
- Aug 16, 2012
-
Artificial retina gives sight to blind mice
- Aug 16, 2012
-
Lucentis approved for diabetic macular edema
- Aug 14, 2012
-
Mayo Clinic: Patients in the dark about prescriptions
- Aug 9, 2012
-
Hospital's plan to prevent painkiller abuse
- Aug 8, 2012
-
Alzheimer's drug disappoints
- Aug 8, 2012
Yaz Actos Belviq lorcaserin Xarelto heart attack dabigatran metal on metal hip replacement Perjeta meningitis Design Nexavar colon cancer Urban type 2 diabetes stroke Photography Washington Video Games EMA GlaxoSmithKline prescription drugs Drugs Nexavar metal-on-metal hip replacement Zimmer generic coumadin dangerous products blood thinners
More Dangerous Drug News
Get News Updates By Email
@ConsumerDrugRep Tweets
Archives
- June 2011 (3)
- September 2011 (1)
- October 2011 (3)
- November 2011 (5)
- December 2011 (25)
- January 2012 (8)
- February 2012 (24)
- March 2012 (20)
- April 2012 (6)
- May 2012 (12)